Tracy Gasson
Adult Health · Sarasota, FLNPI 1194153015
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 180 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,006 and has fallen 94.9% since, to $103 in 2025.
Across 180 payments — averaging $20.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$859
- E.r. Squibb & Sons, L.L.C.$265
- Incyte Corporation$208
- Lilly USA, LLC$208
- AbbVie$202
- Bristol Myers Squibb$169
- plus $2K from 36 others
What the payments were for
- Food & beverage$3,684100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 27 | $859 |
| E.r. Squibb & Sons, L.L.C. | 19 | $265 |
| Incyte Corporation | 10 | $208 |
| Lilly USA, LLC | 9 | $208 |
| AbbVie | 10 | $202 |
| Bristol Myers Squibb | 10 | $169 |
| Seagen Inc. | 10 | $165 |
| Novartis | 7 | $143 |
| Eisai Inc. | 7 | $136 |
| Heron Therapeutics, Inc. | 2 | $133 |
| Amgen | 7 | $124 |
| Daiichi Sankyo Inc. | 5 | $119 |
| Sanofi | 5 | $82 |
| Gilead | 4 | $71 |
| Array Biopharma Inc | 4 | $65 |
| Puma Biotechnology, Inc. | 3 | $54 |
| Jazz Pharmaceuticals Inc. | 3 | $51 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $48 |
| Bayer | 3 | $45 |
| Merck | 2 | $44 |
| Johnson & Johnson(2 entities) | 3 | $43 |
| Boehringer Ingelheim | 2 | $42 |
| Pfizer | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 2 | $33 |
| TG Therapeutics, Inc. | 2 | $30 |
| GT Medical Technologies, Inc | 1 | $29 |
| Astellas Pharma US Inc | 2 | $29 |
| Dova Pharmaceuticals | 2 | $26 |
| Myovant Sciences Inc. | 2 | $24 |
| GSK | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Servier Pharmaceuticals LLC | 1 | $16 |
| GE HealthCare | 1 | $16 |
| EMD Serono, Inc. | 1 | $15 |
| Epizyme, Inc. | 1 | $15 |
| Acrotech Biopharma Inc. | 1 | $15 |
| Agios Pharmaceuticals, Inc. | 1 | $14 |
| Karyopharm Therapeutics Inc. | 1 | $14 |
| AVEO Pharmaceuticals, Inc. | 1 | $14 |
| Boston Scientific | 1 | $12 |
| Taiho Oncology, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,684 in reported general payments places this provider in the 85th percentile of 2,237 adult health providers in Florida.
Other adult health in Sarasota
- Carly KoelschSarasota$265K
- Robin HammackSarasota$11K
- Patricia PagnottaMaitland$409K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Cynthia OteroMaitland$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.